---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-234862"
form_type: "8-K"
ticker: "RLAY"
cik: "0001812364"
company_name: "Relay Therapeutics, Inc."
filed_at: "2026-05-21T21:07:30+00:00"
generated_at: "2026-05-21T21:12:13.692514+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Relay Therapeutics prices $316M public offering; underwriters exercise overallotment

## Summary
- Entered underwriting agreement for 22,916,667 shares at $12.00/sh; full exercise of 3,437,500 overallotment option.
- Net proceeds estimated at ~$296.8M after underwriting discounts and expenses; total shares offered 26,354,167.
- Offering expected to close May 22, 2026, led by Jefferies LLC and TD Securities (USA) LLC.
- Shares sold under existing shelf registration statement; significant dilution to existing shareholders.

## SEC filing metadata
- accession: 0001193125-26-234862
- form_type: 8-K
- ticker: RLAY
- cik: 0001812364
- company_name: Relay Therapeutics, Inc.
- filed_at: 2026-05-21T21:07:30+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812364/000119312526234862/0001193125-26-234862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812364/000119312526234862/d128795d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-234862
- JSON: https://secwatch.observer/filing/0001193125-26-234862.json
- Plain text: https://secwatch.observer/filing/0001193125-26-234862.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.